<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7199731\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="of a novel human coronavirus called SARS-CoV-2 and causing the" exact="respiratory" post="tract disease COVID-19 has reached worldwide resonance and a"/>
  <result pre="novel human coronavirus called SARS-CoV-2 and causing the respiratory tract" exact="disease" post="COVID-19 has reached worldwide resonance and a global effort"/>
  <result pre="SARS-CoV-2 and host receptor recognition, a crucial factor for successful" exact="virus infection" post="and taking immune-informatics approaches to identify B- and T-cell"/>
  <result pre="and host receptor recognition, a crucial factor for successful virus" exact="infection" post="and taking immune-informatics approaches to identify B- and T-cell"/>
  <result pre="using virtual high throughput screening. Highlights â€¢COVID-19 is a highly" exact="infectious disease" post="associated with high mortality. â€¢Rapid and accurate identification of"/>
  <result pre="virtual high throughput screening. Highlights â€¢COVID-19 is a highly infectious" exact="disease" post="associated with high mortality. â€¢Rapid and accurate identification of"/>
  <result pre="drugs. Keywords Coronavirus SARS-CoV-2 COVID-19 Epitopes Immune-informatics Abbreviations COVID-19, Coronavirus" exact="disease" post="2019 ssRNA, single-stranded RNA MERS-CoV, Middle East respiratory syndrome"/>
  <result pre="COVID-19, Coronavirus disease 2019 ssRNA, single-stranded RNA MERS-CoV, Middle East" exact="respiratory" post="syndrome coronavirus SARS-CoV, severe acute respiratory syndrome coronavirus BtCoV,"/>
  <result pre="Coronavirus disease 2019 ssRNA, single-stranded RNA MERS-CoV, Middle East respiratory" exact="syndrome" post="coronavirus SARS-CoV, severe acute respiratory syndrome coronavirus BtCoV, bat"/>
  <result pre="single-stranded RNA MERS-CoV, Middle East respiratory syndrome coronavirus SARS-CoV, severe" exact="acute" post="respiratory syndrome coronavirus BtCoV, bat coronavirus nsp, non-structural proteins"/>
  <result pre="RNA MERS-CoV, Middle East respiratory syndrome coronavirus SARS-CoV, severe acute" exact="respiratory" post="syndrome coronavirus BtCoV, bat coronavirus nsp, non-structural proteins ADE,"/>
  <result pre="MERS-CoV, Middle East respiratory syndrome coronavirus SARS-CoV, severe acute respiratory" exact="syndrome" post="coronavirus BtCoV, bat coronavirus nsp, non-structural proteins ADE, antibody-dependent"/>
  <result pre="ribonucleoprotein NTD, N-terminal RNA-binding domain CTD, C-terminal dimerization domain IBV," exact="infectious" post="bronchitis virus MHV, mouse hepatitis virus ACE2, Angiotensin I"/>
  <result pre="NTD, N-terminal RNA-binding domain CTD, C-terminal dimerization domain IBV, infectious" exact="bronchitis" post="virus MHV, mouse hepatitis virus ACE2, Angiotensin I converting"/>
  <result pre="CTD, C-terminal dimerization domain IBV, infectious bronchitis virus MHV, mouse" exact="hepatitis" post="virus ACE2, Angiotensin I converting enzyme 2 HIV, human"/>
  <result pre="hepatitis virus ACE2, Angiotensin I converting enzyme 2 HIV, human" exact="immunodeficiency" post="virus IVIg, intravenous gammaglobulin PLP, papain-like protease LPV, Lopinavir"/>
  <result pre="there are 6 known human coronaviruses, including the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus"/>
  <result pre="are 6 known human coronaviruses, including the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)."/>
  <result pre="including the Middle East respiratory syndrome coronavirus (MERS-CoV) and severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV). The symptoms caused by Sars-CoV-2"/>
  <result pre="the Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV). The symptoms caused by Sars-CoV-2 infection"/>
  <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV). The symptoms caused by Sars-CoV-2 infection include"/>
  <result pre="acute respiratory syndrome coronavirus (SARS-CoV). The symptoms caused by Sars-CoV-2" exact="infection" post="include acute respiratory distress syndrome (~29%), acute cardiac injury"/>
  <result pre="syndrome coronavirus (SARS-CoV). The symptoms caused by Sars-CoV-2 infection include" exact="acute" post="respiratory distress syndrome (~29%), acute cardiac injury (~12%) or"/>
  <result pre="coronavirus (SARS-CoV). The symptoms caused by Sars-CoV-2 infection include acute" exact="respiratory" post="distress syndrome (~29%), acute cardiac injury (~12%) or acute"/>
  <result pre="The symptoms caused by Sars-CoV-2 infection include acute respiratory distress" exact="syndrome" post="(~29%), acute cardiac injury (~12%) or acute kidney injury"/>
  <result pre="caused by Sars-CoV-2 infection include acute respiratory distress syndrome (~29%)," exact="acute" post="cardiac injury (~12%) or acute kidney injury (~7%) [2],"/>
  <result pre="acute respiratory distress syndrome (~29%), acute cardiac injury (~12%) or" exact="acute" post="kidney injury (~7%) [2], implying that Sars-CoV-2 may infect"/>
  <result pre="respiratory distress syndrome (~29%), acute cardiac injury (~12%) or acute" exact="kidney injury" post="(~7%) [2], implying that Sars-CoV-2 may infect various human"/>
  <result pre="Sars-CoV-2 may infect various human tissues. COVID-19 is a highly" exact="infectious disease" post="[3,4] associated with high mortality [5]. SARS-CoV-2, the virus"/>
  <result pre="may infect various human tissues. COVID-19 is a highly infectious" exact="disease" post="[3,4] associated with high mortality [5]. SARS-CoV-2, the virus"/>
  <result pre="been done to understand the molecular basis of the coronavirus" exact="infection" post="and evolution, develop an effective treatment in forms of"/>
  <result pre="both vaccines and antiviral drugs, and propose efficient measures for" exact="viral" post="detection and prevention [[11], [12], [13]]. Structures of many"/>
  <result pre="related coronaviruses, as well as their biological interactions with other" exact="viral" post="and host proteins, have been explored along with the"/>
  <result pre="by elucidating molecular mechanisms behind virus replication, the process of" exact="viral" post="attachment to the host cells and the effect on"/>
  <result pre="aid in the development of new drugs that interfere with" exact="viral" post="N protein and viral replication in SARS-CoV-2, and highly"/>
  <result pre="of new drugs that interfere with viral N protein and" exact="viral" post="replication in SARS-CoV-2, and highly related virus SARS-CoV. Furthermore,"/>
  <result pre="it is attempted to propose suitable vaccine candidates by identifying" exact="B-Cell" post="and T-cell epitopes with computational approaches for drug and"/>
  <result pre="epitopes with computational approaches for drug and vaccine design. 2" exact="Structural" post="genomics of 2019 Wuhan novel coronavirus Structures of many"/>
  <result pre="related coronaviruses, as well as their biological interactions with other" exact="viral" post="and host proteins, have been explored along with the"/>
  <result pre="interaction network [[30], [31], [32]], and providing molecular insights into" exact="viral" post="evolution [[33], [34], [35]]. By providing a comprehensive structural"/>
  <result pre="ORF7a, ORF7b, ORF8, Nucleocapsid, ORF9a, ORF9b, and ORF10. The three" exact="viral" post="species whose proteins shared the highest similarity were consistently"/>
  <result pre="RNA genomes, like MERS-CoV and SARS-CoV. The first two-thirds of" exact="viral" post="30Â kb RNA genome, mainly named as ORF1a/b region,"/>
  <result pre="protein [37,38] Current antiviral drugs developed to treat coronavirus (CoV)" exact="infections" post="primarily target S protein, the 3C-like (3CL) and papain-like"/>
  <result pre="side effects. Therefore, novel antiviral strategies are needed to combat" exact="acute" post="respiratory infections caused by this novel coronavirus SARS-CoV-2 (Fig."/>
  <result pre="effects. Therefore, novel antiviral strategies are needed to combat acute" exact="respiratory" post="infections caused by this novel coronavirus SARS-CoV-2 (Fig. 1"/>
  <result pre="Therefore, novel antiviral strategies are needed to combat acute respiratory" exact="infections" post="caused by this novel coronavirus SARS-CoV-2 (Fig. 1 )."/>
  <result pre="Like all coronaviruses, Sars-CoV-2 consist of a minimum of three" exact="viral" post="proteins namely spike protein (S), a type of glycoprotein,"/>
  <result pre="the host cell receptors and causes an important role in" exact="viral infection." post="The CoV N protein is a multifunctional RNA-binding protein"/>
  <result pre="CoV N protein is a multifunctional RNA-binding protein necessary for" exact="viral" post="RNA transcription and replication [42]. It plays many pivotal"/>
  <result pre="in forming helical ribonucleoproteins during packaging the RNA genome, regulating" exact="viral" post="RNA synthesis during replication, transcription and modulating infected cell"/>
  <result pre="during replication, transcription and modulating infected cell metabolism [42,43]. The" exact="primary" post="functions of N protein are binding to the viral"/>
  <result pre="The primary functions of N protein are binding to the" exact="viral" post="RNA genome, and packing them into a long helical"/>
  <result pre="highly ordered RNA conformation suitable for replicating, and transcribing the" exact="viral" post="genome [43,45,46]. More studies implicated that N protein regulated"/>
  <result pre="for RNA binding, CTD for oligomerization, and (SR)-rich linker for" exact="primary" post="phosphorylation, respectively [[52], [53], [54]]. The crystal structures of"/>
  <result pre="[[52], [53], [54]]. The crystal structures of SARS-CoV N-NTD [55]," exact="infectious" post="bronchitis virus (IBV) N-NTD [56,57], HCoV-OC43 N-NTD [53] and"/>
  <result pre="[53], [54]]. The crystal structures of SARS-CoV N-NTD [55], infectious" exact="bronchitis" post="virus (IBV) N-NTD [56,57], HCoV-OC43 N-NTD [53] and mouse"/>
  <result pre="bronchitis virus (IBV) N-NTD [56,57], HCoV-OC43 N-NTD [53] and mouse" exact="hepatitis" post="virus (MHV) N-NTD [58] have been solved. The CoVs"/>
  <result pre="been found to associate with the 3â€² end of the" exact="viral" post="RNA genome, possibly through electrostatic interactions. Additionally, several critical"/>
  <result pre="of agents that specifically block the coronavirus replication, transcription and" exact="viral" post="assembly [61]. Kang et al. [62] reported the crystal"/>
  <result pre="aid in the development of new drugs that interfere with" exact="viral" post="N protein and viral replication in SARS-CoV-2, and highly"/>
  <result pre="of new drugs that interfere with viral N protein and" exact="viral" post="replication in SARS-CoV-2, and highly related virus SARS-CoV [62]."/>
  <result pre="cellular protease TMPRSS2 for priming [70], showing that 2019- nCoV" exact="infections" post="also require multiple factors. Understanding the receptorsâ€™ usage by"/>
  <result pre="was mainly expressed in lung AT2, liver cholangiocyte, colon colonocytes," exact="esophagus" post="keratinocytes, ileum ECs, rectum ECs, stomach epithelial cells, and"/>
  <result pre="lung AT2, liver cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs," exact="rectum" post="ECs, stomach epithelial cells, and kidney proximal tubules. Intriguingly"/>
  <result pre="cholangiocyte, colon colonocytes, esophagus keratinocytes, ileum ECs, rectum ECs, stomach" exact="epithelial" post="cells, and kidney proximal tubules. Intriguingly [73], found that"/>
  <result pre="target host cells via binding host receptors before engaging the" exact="infection" post="cycle. ACE2 was proved to be the cell receptor"/>
  <result pre="In previous studies, ACE2 was found to express in the" exact="esophagus" post="upper and stratified epithelial cells, absorptive enterocytes from ileum"/>
  <result pre="previous studies, ACE2 was found to express in the esophagus" exact="upper" post="and stratified epithelial cells, absorptive enterocytes from ileum and"/>
  <result pre="was found to express in the esophagus upper and stratified" exact="epithelial" post="cells, absorptive enterocytes from ileum and colon, alveolar type"/>
  <result pre="stratified epithelial cells, absorptive enterocytes from ileum and colon, alveolar" exact="type II" post="cells in the lung, liver cholangiocyte and kidney proximal"/>
  <result pre="These findings suggested that the clinical symptoms of hepatic failure," exact="respiratory" post="injury, acute kidney injury or diarrhoea may be associated"/>
  <result pre="suggested that the clinical symptoms of hepatic failure, respiratory injury," exact="acute" post="kidney injury or diarrhoea may be associated with the"/>
  <result pre="that the clinical symptoms of hepatic failure, respiratory injury, acute" exact="kidney injury" post="or diarrhoea may be associated with the pervasive ACE2"/>
  <result pre="membrane proteins may also assist virus entry [63]. Since the" exact="viral" post="receptors and co-receptors should be co-expressed on the same"/>
  <result pre="single-cell co-expression patterns covering 400 membrane proteins and 51 known" exact="viral" post="receptors was analyzed [64]. After calculating gene expression similarity,"/>
  <result pre="ACE4 (RÂ &amp;gt;Â 0.8). Interestingly, both ANPEP and DPP4 are" exact="viral" post="receptors of human coronaviruses [75], while ENPEP is also"/>
  <result pre="ENPEP is also a peptidase, despite that its involvement in" exact="virus infection" post="is unclear. For mysterious reasons, human coronaviruses use peptidases"/>
  <result pre="is also a peptidase, despite that its involvement in virus" exact="infection" post="is unclear. For mysterious reasons, human coronaviruses use peptidases"/>
  <result pre="CoVs target similar cell types across different human tissues. 6" exact="General" post="treatment for viral infection Currently, there is no registered"/>
  <result pre="cell types across different human tissues. 6 General treatment for" exact="viral infection" post="Currently, there is no registered treatment or vaccine for"/>
  <result pre="types across different human tissues. 6 General treatment for viral" exact="infection" post="Currently, there is no registered treatment or vaccine for"/>
  <result pre="no registered treatment or vaccine for the disease. In the" exact="absence of" post="a specific treatment for this novel virus, there is"/>
  <result pre="interventions Vitamin A supplementation reduced morbidity and mortality in different" exact="infectious diseases," post="such as measles, diarrheal disease, measles-related pneumonia, human immunodeficiency"/>
  <result pre="infectious diseases, such as measles, diarrheal disease, measles-related pneumonia, human" exact="immunodeficiency" post="virus (HIV) infection, and malaria, as described by Semba"/>
  <result pre="D status in calves had been reported to cause the" exact="infection" post="of Bovine coronavirus [81]. Vitamin E deficiency had been"/>
  <result pre="in calves had been reported to cause the infection of" exact="Bovine" post="coronavirus [81]. Vitamin E deficiency had been reported to"/>
  <result pre="to cause the infection of Bovine coronavirus [81]. Vitamin E" exact="deficiency" post="had been reported to intensify the myocardial injury of"/>
  <result pre="myocardial injury of coxsackievirus B3 (a kind of RNA viruses)" exact="infection" post="in mice [82]. Protection D1, the omega-3 PUFA-derived lipid"/>
  <result pre="influenza virus replication via RNA export machinery [83]. Dietary selenium" exact="deficiency" post="that causes oxidative stress in the host can alter"/>
  <result pre="that causes oxidative stress in the host can alter a" exact="viral" post="genome so that a normally benign or mildly pathogenic"/>
  <result pre="host can alter a viral genome so that a normally" exact="benign" post="or mildly pathogenic virus can become highly virulent in"/>
  <result pre="Iron is required for both host and pathogen and iron" exact="deficiency" post="can impair host immunity, while iron overload can cause"/>
  <result pre="and pathogen and iron deficiency can impair host immunity, while" exact="iron overload" post="can cause oxidative stress to propagate harmful viral mutations"/>
  <result pre="while iron overload can cause oxidative stress to propagate harmful" exact="viral" post="mutations [86]. 6.2 Immunoenhancers A combination of interferon-Î±-2a with"/>
  <result pre="interferon-Î±-2a with ribavirin was administered to patients with severe MERS-CoV" exact="infection" post="and the survival of these patients was improved [87]."/>
  <result pre="extensively in Singapore. However, one-third of critically ill patients developed" exact="venous thromboembolism" post="including pulmonary embolism despite the use of low-molecular-weight heparin"/>
  <result pre="However, one-third of critically ill patients developed venous thromboembolism including" exact="pulmonary embolism" post="despite the use of low-molecular-weight heparin prophylactic [88]. Thymosin"/>
  <result pre="and it was effective in controlling the spread of the" exact="disease" post="[90,91]. Thymopentin (TP5, munox), a synthetic pentapeptide corresponding to"/>
  <result pre="papain-like protease of SARS-CoV [95]. Angiotensin-converting enzyme-2 (ACE2) is a" exact="type I" post="integral membrane protein which that functions as a carboxypeptidase"/>
  <result pre="protein to ACE2 is important for the treatment of SARS-CoV" exact="infection" post="[102]. One recombinant human monoclonal antibody (mAb) (single-chain variable"/>
  <result pre="including antiviral effects. In addition, it had been used against" exact="viral infection" post="[104]. Emodin is an anthraquinone compound derived from genus"/>
  <result pre="antiviral effects. In addition, it had been used against viral" exact="infection" post="[104]. Emodin is an anthraquinone compound derived from genus"/>
  <result pre="from genus Rheum boosted protease inhibitor in the treatment of" exact="HIV infection." post="Lopinavir (LPV) is usually combined with ritonavir (RTV) to"/>
  <result pre="is another potential option to be used to reduce the" exact="infection" post="of COVID-19. 6.4 Antiviral treatments Ribavirin, a broad-spectrum antiviral"/>
  <result pre="Ribavirin, a broad-spectrum antiviral agent, is routinely used to treat" exact="hepatitis C" post="[110]. Morgenstern et al. [111] had reported that ribavirin"/>
  <result pre="used as a boosted protease inhibitor in the treatment of" exact="HIV infection" post="[112]. Kim et al. [113] had also reported a"/>
  <result pre="as a boosted protease inhibitor in the treatment of HIV" exact="infection" post="[112]. Kim et al. [113] had also reported a"/>
  <result pre="al. [113] had also reported a successful case of MERS-CoV" exact="disease" post="treated with triple combination therapy LPV/RTV, ribavirin, and IFN-Î±2a."/>
  <result pre="human and zoonotic coronavirus in vitro and to restrain severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) in vivo [114]. Recently, the"/>
  <result pre="and zoonotic coronavirus in vitro and to restrain severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) in vivo [114]. Recently, the antiviral"/>
  <result pre="zoonotic coronavirus in vitro and to restrain severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) in vivo [114]. Recently, the antiviral activity"/>
  <result pre="for COVIDâ€�19. Table 1 Compounds Virus target Functions Representative References" exact="General" post="treatments for viral infection Nutritional interventions Vitamin A Measles"/>
  <result pre="1 Compounds Virus target Functions Representative References General treatments for" exact="viral infection" post="Nutritional interventions Vitamin A Measles virus, avian coronavirus Prevention"/>
  <result pre="Compounds Virus target Functions Representative References General treatments for viral" exact="infection" post="Nutritional interventions Vitamin A Measles virus, avian coronavirus Prevention"/>
  <result pre="injury Enhance their immune system (Keil, Bowen et al., 2016)" exact="Vitamin C" post="Avian coronavirus; lower respiratory tract infections Act as an"/>
  <result pre="their immune system (Keil, Bowen et al., 2016) Vitamin C" exact="Avian" post="coronavirus; lower respiratory tract infections Act as an antioxidant"/>
  <result pre="system (Keil, Bowen et al., 2016) Vitamin C Avian coronavirus;" exact="lower" post="respiratory tract infections Act as an antioxidant (Atherton, Kratzing"/>
  <result pre="(Keil, Bowen et al., 2016) Vitamin C Avian coronavirus; lower" exact="respiratory" post="tract infections Act as an antioxidant (Atherton, Kratzing et"/>
  <result pre="et al., 2016) Vitamin C Avian coronavirus; lower respiratory tract" exact="infections" post="Act as an antioxidant (Atherton, Kratzing et al., 1978)"/>
  <result pre="as an antioxidant (Atherton, Kratzing et al., 1978) Vitamin D" exact="Bovine" post="coronavirus Maintaining bone integrity (Nonnecke, McGill et al., 2014)"/>
  <result pre="stress (Beck, Kolbeck et al., 1994) PUFAa Influenza virus, human" exact="immunodeficiency" post="virus Antiâ€�inflammatory and proâ€�inflammatory effects. (Morita, Kuba et al.,"/>
  <result pre="(Morita, Kuba et al., 2013) Selenium Influenza virus, avian coronavirus;" exact="viral" post="mutations Defense against infectious diseases (Rayman 2012) Zinc Measles"/>
  <result pre="2013) Selenium Influenza virus, avian coronavirus; viral mutations Defense against" exact="infectious diseases" post="(Rayman 2012) Zinc Measles virus, SARSâ€�CoV Maintaining immune system"/>
  <result pre="system (Te Velthuis, van den Worm et al., 2010) Iron" exact="Viral" post="mutations Development of recurrent acute respiratory infections (Wessling-Resnick 2018)"/>
  <result pre="den Worm et al., 2010) Iron Viral mutations Development of" exact="recurrent" post="acute respiratory infections (Wessling-Resnick 2018) Immunoenhancers Interferons SARSâ€�CoV, MERSâ€�CoV"/>
  <result pre="Worm et al., 2010) Iron Viral mutations Development of recurrent" exact="acute" post="respiratory infections (Wessling-Resnick 2018) Immunoenhancers Interferons SARSâ€�CoV, MERSâ€�CoV Immune"/>
  <result pre="et al., 2010) Iron Viral mutations Development of recurrent acute" exact="respiratory" post="infections (Wessling-Resnick 2018) Immunoenhancers Interferons SARSâ€�CoV, MERSâ€�CoV Immune response"/>
  <result pre="al., 2010) Iron Viral mutations Development of recurrent acute respiratory" exact="infections" post="(Wessling-Resnick 2018) Immunoenhancers Interferons SARSâ€�CoV, MERSâ€�CoV Immune response to"/>
  <result pre="infections (Wessling-Resnick 2018) Immunoenhancers Interferons SARSâ€�CoV, MERSâ€�CoV Immune response to" exact="virus infection." post="(Momattin, Al-Ali et al., 2018) Intravenous gammaglobulin SARSâ€�CoV Increase"/>
  <result pre="resistance to glucocorticoidâ€�induced death (Baumann, Badamchian et al., 1997) Thymopentin" exact="hepatitis" post="B Restore antibody production (Duchateau, Servais et al., 1985)"/>
  <result pre="agent (Joffe, Sukha et al., 1983) Cyclosporine A SARSâ€�CoV, avian" exact="infectious" post="bronchitis virus Treatment of autoimmune disorders (Luo, Luo et"/>
  <result pre="(Joffe, Sukha et al., 1983) Cyclosporine A SARSâ€�CoV, avian infectious" exact="bronchitis" post="virus Treatment of autoimmune disorders (Luo, Luo et al.,"/>
  <result pre="1983) Cyclosporine A SARSâ€�CoV, avian infectious bronchitis virus Treatment of" exact="autoimmune" post="disorders (Luo, Luo et al., 2004) Coronavirusâ€�specific treatments Coronavirus"/>
  <result pre="tumors (Sui, Li et al., 2004) Chloroquine SARSâ€�CoV Prevention of" exact="malaria" post="in adults (Savarino, Boelaert et al., 2003) Emodin SARSâ€�CoV"/>
  <result pre="Boelaert et al., 2003) Emodin SARSâ€�CoV Pancreatic disease, inflammatory, and" exact="diabetes" post="(Vickers 2017) Promazine SARSâ€�CoV Using in paranoid and manic-depressive"/>
  <result pre="disease, inflammatory, and diabetes (Vickers 2017) Promazine SARSâ€�CoV Using in" exact="paranoid" post="and manic-depressive conditions, (Cauwenberghs, Feijge et al., 2006) Nicotianamine"/>
  <result pre="(Cauwenberghs, Feijge et al., 2006) Nicotianamine SARSâ€�CoV To reduce the" exact="infection" post="(Cauwenberghs, Feijge et al., 2006) Antiviral treatments Ribavirin SARSâ€�CoV"/>
  <result pre="Feijge et al., 2006) Antiviral treatments Ribavirin SARSâ€�CoV Treatment of" exact="hepatitis C" post="(Ksiazek, Erdman et al., 2003) (LPV)b/(RTV)c (Kaletra) MERSâ€�CoV Treatment"/>
  <result pre="(Ksiazek, Erdman et al., 2003) (LPV)b/(RTV)c (Kaletra) MERSâ€�CoV Treatment of" exact="HIV infection" post="(Tsang and Zhong 2003) Remdesivir SARSâ€�CoV/MERSâ€�CoV Treatment of Ebola"/>
  <result pre="Erdman et al., 2003) (LPV)b/(RTV)c (Kaletra) MERSâ€�CoV Treatment of HIV" exact="infection" post="(Tsang and Zhong 2003) Remdesivir SARSâ€�CoV/MERSâ€�CoV Treatment of Ebola"/>
  <result pre="(Tsang and Zhong 2003) Remdesivir SARSâ€�CoV/MERSâ€�CoV Treatment of Ebola virus" exact="disease" post="and Marburg virus (Yamamoto, Yang et al., 2004) Nelfinavir"/>
  <result pre="HIV (Mohanasundaram and Sekhar 2018) Arbidol SARSâ€�CoV Treatment for influenza" exact="infection" post="(Khamitov, Loginova et al., 2008) Nitric oxide SARSâ€�CoV Treatment"/>
  <result pre="et al., 2008) Nitric oxide SARSâ€�CoV Treatment of inflammatory airway" exact="disease" post="(Robbins and Grisham 1997) aOmegaâ€�3 polyunsaturated fatty acid. bLopinavir."/>
  <result pre="is an effective strategy to combat novel diseases caused by" exact="infectious" post="agents that spread rapidly [123]. Drugs that have been"/>
  <result pre="safe for human use, and only their effectiveness against the" exact="disease" post="of interest needs to be established [124]. In life-threatening"/>
  <result pre="some of the drugs approved for the treatment of other" exact="viral" post="infections also have the potential for the treatment of"/>
  <result pre="of the drugs approved for the treatment of other viral" exact="infections" post="also have the potential for the treatment of COVID-19."/>
  <result pre="of patients. During the epidemic and pandemic outbreak of new" exact="viral" post="pathogens, the conventional method of development of drugs and"/>
  <result pre="increase of patients and a high mortality rate of Sars-CoV-2" exact="infection" post="highlight the urgent need for the development of a"/>
  <result pre="receptor [134]. 3C like proteinase (3CLpro) plays a role in" exact="viral" post="pathogenicity and replication by clevaging the polyprotein. The inhibitors"/>
  <result pre="inhibitors of 3CLpro can block the clevage reaction thereby controlling" exact="viral" post="replication and pathogenicity [135]. The natural inhibitors were used"/>
  <result pre="bioinformatics tools, attempting to identify suitable vaccine candidates by identifying" exact="B-Cell" post="and T-cell epitopes [137]. In the drug design, the"/>
  <result pre="peptide vaccine design and target site characterization against novel coronavirus" exact="Structural" post="proteins are important targets for vaccine and anti-viral drug"/>
  <result pre="conformation that undergoes a dramatic structural rearrangement to fuse the" exact="viral" post="membrane with the host-cell membrane [141,142]. The S protein"/>
  <result pre="and the state transition of the S2 subunit to a" exact="stable" post="postfusion conformation [143]. The critical function of the S"/>
  <result pre="no licensed therapeutic or vaccine for the treatment of SARS-CoV-2" exact="infection" post="available in the market. Developing an effective treatment for"/>
  <result pre="is more efficient and more applicable for deep analysis of" exact="viral" post="antigens, B- and T-cell linear epitope prediction, and evaluation"/>
  <result pre="be analyzed, B-cell can recognize and activate defense responses against" exact="viral infection," post="T-cell and antibody reactions may recover extreme respiratory infection"/>
  <result pre="against viral infection, T-cell and antibody reactions may recover extreme" exact="respiratory" post="infection (Fig. 2 ). Fig. 2 The overall workflow"/>
  <result pre="viral infection, T-cell and antibody reactions may recover extreme respiratory" exact="infection" post="(Fig. 2 ). Fig. 2 The overall workflow of"/>
  <result pre="to ACE2 expression the lung, which in turn may mediate" exact="susceptibility to" post="Sars-CoV-2 infection. In addition, the proteome-wide MR analysis revealed"/>
  <result pre="Infect. Dis.91202026426631953166 6GuoY.-R.CaoQ.-D.HongZ.-S.TanY.-Y.ChenS.-D.JinH.-J.The origin, transmission and clinical therapies on coronavirus" exact="disease" post="2019 (COVID-19) outbreakâ€&quot;an update on the statusMil. Med. Res.7202011031928528"/>
  <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting WuhanEmerg. Microb. Infect.92020221236 8WuF.ZhaoS.YuB.ChenY.-M.WangW.SongZ.-G.A new coronavirus associated"/>
  <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting WuhanEmerg. Microb. Infect.92020221236 8WuF.ZhaoS.YuB.ChenY.-M.WangW.SongZ.-G.A new coronavirus associated"/>
  <result pre="visiting WuhanEmerg. Microb. Infect.92020221236 8WuF.ZhaoS.YuB.ChenY.-M.WangW.SongZ.-G.A new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature579202026526932015508 9ChenJ.Pathogenicity and transmissibility of 2019-nCoVâ€&quot;a quick"/>
  <result pre="WuhanEmerg. Microb. Infect.92020221236 8WuF.ZhaoS.YuB.ChenY.-M.WangW.SongZ.-G.A new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature579202026526932015508 9ChenJ.Pathogenicity and transmissibility of 2019-nCoVâ€&quot;a quick overview"/>
  <result pre="binding domainsNat. Commun.820171509228393837 12CottenM.WatsonS.J.KellamP.Al-RabeeahA.A.MakhdoomH.Q.AssiriA.Transmission and evolution of the Middle East" exact="respiratory" post="syndrome coronavirus in Saudi Arabia: a descriptive genomic studyLancet38220131993200224055451"/>
  <result pre="domainsNat. Commun.820171509228393837 12CottenM.WatsonS.J.KellamP.Al-RabeeahA.A.MakhdoomH.Q.AssiriA.Transmission and evolution of the Middle East respiratory" exact="syndrome" post="coronavirus in Saudi Arabia: a descriptive genomic studyLancet38220131993200224055451 13FathizadehH.MaroufiP.Momen-HeraviM.DaoS.KÃ¶seÅž.GanbarovK.Protection"/>
  <result pre="13FathizadehH.MaroufiP.Momen-HeraviM.DaoS.KÃ¶seÅž.GanbarovK.Protection and disinfection policies against SARS-CoV-2 (COVID-19)Inf. Med.282020 14KillerbyM.E.BiggsH.M.MidgleyC.M.GerberS.I.WatsonJ.T.Middle East" exact="respiratory" post="syndrome coronavirus transmissionEmerg. Infect. Dis.26202019131961300 15ChoC.-C.LinM.-H.ChuangC.-Y.HsuC.-H.Macro domain from Middle"/>
  <result pre="and disinfection policies against SARS-CoV-2 (COVID-19)Inf. Med.282020 14KillerbyM.E.BiggsH.M.MidgleyC.M.GerberS.I.WatsonJ.T.Middle East respiratory" exact="syndrome" post="coronavirus transmissionEmerg. Infect. Dis.26202019131961300 15ChoC.-C.LinM.-H.ChuangC.-Y.HsuC.-H.Macro domain from Middle East"/>
  <result pre="syndrome coronavirus transmissionEmerg. Infect. Dis.26202019131961300 15ChoC.-C.LinM.-H.ChuangC.-Y.HsuC.-H.Macro domain from Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) is an efficient ADP-ribose binding module"/>
  <result pre="coronavirus transmissionEmerg. Infect. Dis.26202019131961300 15ChoC.-C.LinM.-H.ChuangC.-Y.HsuC.-H.Macro domain from Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) is an efficient ADP-ribose binding module crystal"/>
  <result pre="genome projectNat. Genet.23199915115710508510 22WichapongK.PianwanitS.SipplW.KokpolS.Homology modeling and molecular dynamics simulations of" exact="Dengue" post="virus NS2B/NS3 protease: insight into molecular interactionJ. Mol. Recogn.:"/>
  <result pre="36SrinivasanS.CuiH.GaoZ.LiuM.LuS.MkandawireW.NarykovO.SunM.KorkinD.Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of" exact="Viral" post="ProteinsViruses122020360 37CuiJ.LiF.ShiZ.-L.Origin and evolution of pathogenic coronavirusesNat. Rev. Microbiol.17201918119230531947"/>
  <result pre="mouse coronavirus spike protein complexed with receptor reveals mechanism for" exact="viral" post="entryPLoS Pathog.162020e1008392 42NelsonG.W.StohlmanS.A.TaharaS.M.High affinity interaction between nucleocapsid protein and"/>
  <result pre="affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse" exact="hepatitis" post="virus RNAJ. Gen. Virol.81200018118810640556 43CongY.UlasliM.SchepersH.MautheM.Vâ€™kovskiP.KriegenburgF.Nucleocapsid protein recruitment to replication-transcription"/>
  <result pre="proteinViruses620142991301825105276 46TangT.K.WuM.P.J.ChenS.T.HouM.H.HongM.H.PanF.M.Biochemical and immunological studies of nucleocapsid proteins of severe" exact="acute" post="respiratory syndrome and 229E human coronavirusesProteomics5200592593715759315 47DuL.ZhaoG.LinY.ChanC.HeY.JiangS.Priming with rAAV"/>
  <result pre="46TangT.K.WuM.P.J.ChenS.T.HouM.H.HongM.H.PanF.M.Biochemical and immunological studies of nucleocapsid proteins of severe acute" exact="respiratory" post="syndrome and 229E human coronavirusesProteomics5200592593715759315 47DuL.ZhaoG.LinY.ChanC.HeY.JiangS.Priming with rAAV encoding"/>
  <result pre="and immunological studies of nucleocapsid proteins of severe acute respiratory" exact="syndrome" post="and 229E human coronavirusesProteomics5200592593715759315 47DuL.ZhaoG.LinY.ChanC.HeY.JiangS.Priming with rAAV encoding RBD"/>
  <result pre="and cellular immune responses against SARS-CoV infectionVaccine2620081644165118289745 48HsiehP.-K.ChangS.C.HuangC.-C.LeeT.-T.HsiaoC.-W.KouY.-H.Assembly of severe" exact="acute" post="respiratory syndrome coronavirus RNA packaging signal into virus-like particles"/>
  <result pre="cellular immune responses against SARS-CoV infectionVaccine2620081644165118289745 48HsiehP.-K.ChangS.C.HuangC.-C.LeeT.-T.HsiaoC.-W.KouY.-H.Assembly of severe acute" exact="respiratory" post="syndrome coronavirus RNA packaging signal into virus-like particles is"/>
  <result pre="immune responses against SARS-CoV infectionVaccine2620081644165118289745 48HsiehP.-K.ChangS.C.HuangC.-C.LeeT.-T.HsiaoC.-W.KouY.-H.Assembly of severe acute respiratory" exact="syndrome" post="coronavirus RNA packaging signal into virus-like particles is nucleocapsid"/>
  <result pre="RNA-binding domain of human coronavirus OC43 nucleocapsid proteinBiochim. Biophys. Acta" exact="Protein" post="Proteonomics1834201310541062 54ChangC-kChenC.-M.M.ChiangM-hHsuY-lHuangT-hTransient oligomerization of the SARS-CoV N proteinâ€&quot;implication for"/>
  <result pre="proteinâ€&quot;implication for virus ribonucleoprotein packagingPloS One82013 55SaikatenduK.S.JosephJ.S.SubramanianV.NeumanB.W.BuchmeierM.J.StevensR.C.Ribonucleocapsid formation of severe" exact="acute" post="respiratory syndrome coronavirus through molecular action of the N-terminal"/>
  <result pre="for virus ribonucleoprotein packagingPloS One82013 55SaikatenduK.S.JosephJ.S.SubramanianV.NeumanB.W.BuchmeierM.J.StevensR.C.Ribonucleocapsid formation of severe acute" exact="respiratory" post="syndrome coronavirus through molecular action of the N-terminal domain"/>
  <result pre="virus ribonucleoprotein packagingPloS One82013 55SaikatenduK.S.JosephJ.S.SubramanianV.NeumanB.W.BuchmeierM.J.StevensR.C.Ribonucleocapsid formation of severe acute respiratory" exact="syndrome" post="coronavirus through molecular action of the N-terminal domain of"/>
  <result pre="implications for nucleocapsid formationJ. Virol.8020066612662016775348 57FanH.OoiA.TanY.W.WangS.FangS.LiuD.X.The nucleocapsid protein of coronavirus" exact="infectious" post="bronchitis virus: crystal structure of its N-terminal domain and"/>
  <result pre="for nucleocapsid formationJ. Virol.8020066612662016775348 57FanH.OoiA.TanY.W.WangS.FangS.LiuD.X.The nucleocapsid protein of coronavirus infectious" exact="bronchitis" post="virus: crystal structure of its N-terminal domain and multimerization"/>
  <result pre="sequence (TRS) RNA binding and helix destabilizing determinants of murine" exact="hepatitis" post="virus (MHV) nucleocapsid (N) proteinJ. Biol. Chem.28720127063707322241479 61LinS.-M.LinS.-C.HsuJ.-N.ChangC-kChienC.-M.WangY.-S.Structure-based stabilization"/>
  <result pre="an analysis of single-cell coexpression pattern of key proteins in" exact="viral" post="entry processGut202010.1136/gutjnl-2020-320953 68ZouX.ChenK.ZouJ.HanP.HaoJ.HanZ.Single-cell RNA-seq data analysis on the receptor"/>
  <result pre="glycoprotein of Marburg virus and the S protein of severe" exact="acute" post="respiratory syndrome coronavirusJ. Virol.782004120901209515479853 75PeckK.M.ScobeyT.SwanstromJ.JensenK.L.BurchC.L.BaricR.S.Permissivity of dipeptidyl peptidase 4"/>
  <result pre="of Marburg virus and the S protein of severe acute" exact="respiratory" post="syndrome coronavirusJ. Virol.782004120901209515479853 75PeckK.M.ScobeyT.SwanstromJ.JensenK.L.BurchC.L.BaricR.S.Permissivity of dipeptidyl peptidase 4 orthologs"/>
  <result pre="Marburg virus and the S protein of severe acute respiratory" exact="syndrome" post="coronavirusJ. Virol.782004120901209515479853 75PeckK.M.ScobeyT.SwanstromJ.JensenK.L.BurchC.L.BaricR.S.Permissivity of dipeptidyl peptidase 4 orthologs to"/>
  <result pre="Virol.782004120901209515479853 75PeckK.M.ScobeyT.SwanstromJ.JensenK.L.BurchC.L.BaricR.S.Permissivity of dipeptidyl peptidase 4 orthologs to Middle East" exact="respiratory" post="syndrome coronavirus is governed by glycosylation and other complex"/>
  <result pre="75PeckK.M.ScobeyT.SwanstromJ.JensenK.L.BurchC.L.BaricR.S.Permissivity of dipeptidyl peptidase 4 orthologs to Middle East respiratory" exact="syndrome" post="coronavirus is governed by glycosylation and other complex determinantsJ."/>
  <result pre="pneumoniaN. Engl. J. Med.38220201199120731995857 78SembaR.D.Vitamin A and immunity to viral," exact="bacterial" post="and protozoan infectionsProc. Nutr. Soc.58199971972710604208 79KeilS.D.BowenR.MarschnerS.Inactivation of M iddle"/>
  <result pre="protozoan infectionsProc. Nutr. Soc.58199971972710604208 79KeilS.D.BowenR.MarschnerS.Inactivation of M iddle E ast" exact="respiratory" post="syndrome coronavirus (MERSâ€�C o V) in plasma products using"/>
  <result pre="infectionsProc. Nutr. Soc.58199971972710604208 79KeilS.D.BowenR.MarschnerS.Inactivation of M iddle E ast respiratory" exact="syndrome" post="coronavirus (MERSâ€�C o V) in plasma products using a"/>
  <result pre="ultraviolet lightâ€�based photochemical treatmentTransfusion5620162948295227805261 80AthertonJ.KratzingC.FisherA.The effect of ascorbic acid on" exact="infection" post="of chick-embryo ciliated tracheal organ cultures by coronavirusArch. Virol.561978195199205194"/>
  <result pre="by coronavirusArch. Virol.561978195199205194 81NonneckeB.McGillJ.RidpathJ.SaccoR.LippolisJ.ReinhardtT.Acute phase response elicited by experimental bovine" exact="diarrhea" post="virus (BVDV) infection is associated with decreased vitamin D"/>
  <result pre="81NonneckeB.McGillJ.RidpathJ.SaccoR.LippolisJ.ReinhardtT.Acute phase response elicited by experimental bovine diarrhea virus (BVDV)" exact="infection" post="is associated with decreased vitamin D and E status"/>
  <result pre="E status of vitamin-replete preruminant calvesJ. Dairy Sci.9720145566557925022687 82BeckM.A.KolbeckP.C.RohrL.H.ShiQ.MorrisV.C.LevanderO.A.Vitamin E" exact="deficiency" post="intensifies the myocardial injury of coxsackievirus B3 infection of"/>
  <result pre="82BeckM.A.KolbeckP.C.RohrL.H.ShiQ.MorrisV.C.LevanderO.A.Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3" exact="infection" post="of miceJ. Nutr.12419943453588120653 83MoritaM.KubaK.IchikawaA.NakayamaM.KatahiraJ.IwamotoR.The lipid mediator protectin D1 inhibits"/>
  <result pre="86Wessling-ResnickM.Crossing the iron gate: why and how transferrin receptors mediate" exact="viral" post="entryAnnu. Rev. Nutr.38201843145829852086 87MomattinH.Al-AliA.Y.MohammedK.Al-TawfiqJ.A.Benchmarking of antibiotic usage: an adjustment"/>
  <result pre="in a hospital in Saudi ArabiaJ. Infect. Publ. Health112018310313 88LewT.W.KwekT.-K.TaiD.EarnestA.LooS.SinghK.Acute" exact="respiratory" post="distress syndrome in critically ill patients with severe acute"/>
  <result pre="hospital in Saudi ArabiaJ. Infect. Publ. Health112018310313 88LewT.W.KwekT.-K.TaiD.EarnestA.LooS.SinghK.Acute respiratory distress" exact="syndrome" post="in critically ill patients with severe acute respiratory syndromeJAMA290200337438012865379"/>
  <result pre="88LewT.W.KwekT.-K.TaiD.EarnestA.LooS.SinghK.Acute respiratory distress syndrome in critically ill patients with severe" exact="acute" post="respiratory syndromeJAMA290200337438012865379 89BaumannC.A.BadamchianM.GoldsteinA.L.Thymosin Î±1 antagonizes dexamethasone and CD3-induced apoptosis"/>
  <result pre="respiratory distress syndrome in critically ill patients with severe acute" exact="respiratory" post="syndromeJAMA290200337438012865379 89BaumannC.A.BadamchianM.GoldsteinA.L.Thymosin Î±1 antagonizes dexamethasone and CD3-induced apoptosis of"/>
  <result pre="pathwaysMech. Ageing Dev.941997851019147362 90GaoZ.ZhuJ.SunY.DingX.MaJ.CuiY.Clinical investigation of outbreak of nosocomial severe" exact="acute" post="respiratory syndrome. Protection and disinfection policies against SARS-CoV-2 (COVID-19)Chin."/>
  <result pre="Ageing Dev.941997851019147362 90GaoZ.ZhuJ.SunY.DingX.MaJ.CuiY.Clinical investigation of outbreak of nosocomial severe acute" exact="respiratory" post="syndrome. Protection and disinfection policies against SARS-CoV-2 (COVID-19)Chin. Crit."/>
  <result pre="Commun.321200455756515358143 95ParkJ.-Y.JeongH.J.KimJ.H.KimY.M.ParkS.-J.KimD.Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe" exact="acute" post="respiratory syndrome coronavirusBiol. Pharm. Bull.351120122036204222971649 96ChenL.GuiC.LuoX.YangQ.GÃ¼ntherS.ScandellaE.Cinanserin is an inhibitor"/>
  <result pre="95ParkJ.-Y.JeongH.J.KimJ.H.KimY.M.ParkS.-J.KimD.Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute" exact="respiratory" post="syndrome coronavirusBiol. Pharm. Bull.351120122036204222971649 96ChenL.GuiC.LuoX.YangQ.GÃ¼ntherS.ScandellaE.Cinanserin is an inhibitor of"/>
  <result pre="from Alnus japonica inhibit papain-like protease of severe acute respiratory" exact="syndrome" post="coronavirusBiol. Pharm. Bull.351120122036204222971649 96ChenL.GuiC.LuoX.YangQ.GÃ¼ntherS.ScandellaE.Cinanserin is an inhibitor of the"/>
  <result pre="96ChenL.GuiC.LuoX.YangQ.GÃ¼ntherS.ScandellaE.Cinanserin is an inhibitor of the 3C-like proteinase of severe" exact="acute" post="respiratory syndrome coronavirus and strongly reduces virus replication in"/>
  <result pre="is an inhibitor of the 3C-like proteinase of severe acute" exact="respiratory" post="syndrome coronavirus and strongly reduces virus replication in vitroJ."/>
  <result pre="an inhibitor of the 3C-like proteinase of severe acute respiratory" exact="syndrome" post="coronavirus and strongly reduces virus replication in vitroJ. Virol.7920057095710315890949"/>
  <result pre="novel coronavirus in China: a systematic reviewJ. Med. Virol.925202047949032052466 102YeungK.S.YamanakaG.A.MeanwellN.A.Severe" exact="acute" post="respiratory syndrome coronavirus entry into host cells: opportunities for"/>
  <result pre="coronavirus in China: a systematic reviewJ. Med. Virol.925202047949032052466 102YeungK.S.YamanakaG.A.MeanwellN.A.Severe acute" exact="respiratory" post="syndrome coronavirus entry into host cells: opportunities for therapeutic"/>
  <result pre="in China: a systematic reviewJ. Med. Virol.925202047949032052466 102YeungK.S.YamanakaG.A.MeanwellN.A.Severe acute respiratory" exact="syndrome" post="coronavirus entry into host cells: opportunities for therapeutic interventionMed."/>
  <result pre="opportunities for therapeutic interventionMed. Res. Rev.26200641443316521129 103SuiJ.LiW.MurakamiA.TaminA.MatthewsL.J.WongS.K.Potent neutralization of severe" exact="acute" post="respiratory syndrome (SARS) coronavirus by a human mAb to"/>
  <result pre="for therapeutic interventionMed. Res. Rev.26200641443316521129 103SuiJ.LiW.MurakamiA.TaminA.MatthewsL.J.WongS.K.Potent neutralization of severe acute" exact="respiratory" post="syndrome (SARS) coronavirus by a human mAb to S1"/>
  <result pre="therapeutic interventionMed. Res. Rev.26200641443316521129 103SuiJ.LiW.MurakamiA.TaminA.MatthewsL.J.WongS.K.Potent neutralization of severe acute respiratory" exact="syndrome" post="(SARS) coronavirus by a human mAb to S1 protein"/>
  <result pre="Natl. Acad. Sci. Unit. States Am.101200425362541 104SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of chloroquine on" exact="viral" post="infections: an old drug against today's diseasesLancet Infect. Dis.3200372272714592603"/>
  <result pre="inhibitor in soybeanBiomed. Res.36201521922426106051 110KsiazekT.G.ErdmanD.GoldsmithC.S.ZakiS.R.PeretT.EmeryS.A novel coronavirus associated with severe" exact="acute" post="respiratory syndromeN. Engl. J. Med.34820031953196612690092 111MorgensternB.MichaelisM.BaerP.C.DoerrH.W.CinatlJ.Jr.Ribavirin and interferon-Î² synergistically"/>
  <result pre="in soybeanBiomed. Res.36201521922426106051 110KsiazekT.G.ErdmanD.GoldsmithC.S.ZakiS.R.PeretT.EmeryS.A novel coronavirus associated with severe acute" exact="respiratory" post="syndromeN. Engl. J. Med.34820031953196612690092 111MorgensternB.MichaelisM.BaerP.C.DoerrH.W.CinatlJ.Jr.Ribavirin and interferon-Î² synergistically inhibit"/>
  <result pre="Combination therapy with lopinavir/ritonavir, ribavirin and interferon-Î± for Middle East" exact="respiratory" post="syndromeAntivir. Ther.21201645545926492219 114AgostiniM.L.AndresE.L.SimsA.C.GrahamR.L.SheahanT.P.LuX.Coronavirus susceptibility to the antiviral remdesivir (GS-5734)"/>
  <result pre="ribavirin and interferon-Î± for Middle East respiratory syndromeAntivir. Ther.21201645545926492219 114AgostiniM.L.AndresE.L.SimsA.C.GrahamR.L.SheahanT.P.LuX.Coronavirus" exact="susceptibility to" post="the antiviral remdesivir (GS-5734) is mediated by the viral"/>
  <result pre="susceptibility to the antiviral remdesivir (GS-5734) is mediated by the" exact="viral" post="polymerase and the proofreading exoribonucleasemBio92018e00221-18 115SheahanT.P.SimsA.C.LeistS.R.SchÃ¤ferA.WonJ.BrownA.J.Comparative therapeutic efficacy of"/>
  <result pre="of arbidol and its derivatives against the pathogen of severe" exact="acute" post="respiratory syndrome in the cell culturesVopr. Virusol.532008913 118RobbinsR.A.GrishamM.B.Nitric oxideInt."/>
  <result pre="arbidol and its derivatives against the pathogen of severe acute" exact="respiratory" post="syndrome in the cell culturesVopr. Virusol.532008913 118RobbinsR.A.GrishamM.B.Nitric oxideInt. J."/>
  <result pre="and its derivatives against the pathogen of severe acute respiratory" exact="syndrome" post="in the cell culturesVopr. Virusol.532008913 118RobbinsR.A.GrishamM.B.Nitric oxideInt. J. Biochem."/>
  <result pre="Cell Biol.2919978578609304799 119Ã…kerstrÃ¶mS.Mousavi-JaziM.KlingstrÃ¶mJ.LeijonM.Ã…LundkvistMirazimiA.Nitric oxide inhibits the replication cycle of severe" exact="acute" post="respiratory syndrome coronavirusJ. Virol.7920051966196915650225 120TalluriS.Virtual High Throughput Screening Based"/>
  <result pre="Biol.2919978578609304799 119Ã…kerstrÃ¶mS.Mousavi-JaziM.KlingstrÃ¶mJ.LeijonM.Ã…LundkvistMirazimiA.Nitric oxide inhibits the replication cycle of severe acute" exact="respiratory" post="syndrome coronavirusJ. Virol.7920051966196915650225 120TalluriS.Virtual High Throughput Screening Based Prediction"/>
  <result pre="119Ã…kerstrÃ¶mS.Mousavi-JaziM.KlingstrÃ¶mJ.LeijonM.Ã…LundkvistMirazimiA.Nitric oxide inhibits the replication cycle of severe acute respiratory" exact="syndrome" post="coronavirusJ. Virol.7920051966196915650225 120TalluriS.Virtual High Throughput Screening Based Prediction of"/>
  <result pre="Pharmacol. Sci.34201326727223582281 126LiuX.ZhangB.JinZ.YangH.RaoZ.The Crystal Structure of 2019-NCoV Main Protease in" exact="Complex" post="with an Inhibitor N32020RCSB Protein Data Bank 127ChenY.LiuQ.GuoD.Emerging coronaviruses:"/>
  <result pre="of 2019-NCoV Main Protease in Complex with an Inhibitor N32020RCSB" exact="Protein" post="Data Bank 127ChenY.LiuQ.GuoD.Emerging coronaviruses: genome structure, replication, and pathogenesisJ."/>
  <result pre="Protoc.10201584585825950237 139KumarS.Drug and Vaccine Design against Novel Coronavirus (2019-nCoV) Spike" exact="Protein" post="through Computational Approach2020 140LindenbachB.D.RiceC.M.Molecular biology of flavivirusesAdv. Virus Res.592003236214696326"/>
  <result pre="Natl. Acad. Sci. Unit. States Am.11420171115711162 144ul QamarM.T.BariA.AdeelM.M.MaryamA.AshfaqU.A.DuX.Peptide vaccine against" exact="chikungunya" post="virus: immuno-informatics combined with molecular docking approachJ. Transl. Med.16201829830368237"/>
  <result pre="approachJ. Transl. Med.16201829830368237 145LiL.SunT.HeY.LiW.FanY.ZhangJ.Epitope-based peptide vaccines predicted against novel coronavirus" exact="disease" post="caused by SARS-CoV-2BioRxiv2020Preprint Acknowledgment We thank all staff of"/>
 </snippets>
</snippetsTree>
